Recap: Novozymes Q4 Earnings
Portfolio Pulse from Benzinga Insights
Novozymes (OTC:NVZMY) reported Q4 earnings with an EPS of $0.36, missing estimates by 18.18% against an expected $0.44. Revenue increased by $58.13 million from the previous year. In contrast, the company had previously beaten EPS estimates in Q3 2023, leading to a 2.66% share price increase the following day.
February 01, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Novozymes reported a significant miss in Q4 earnings with an EPS of $0.36 against the expected $0.44, but showed an increase in revenue compared to last year.
Missing the EPS estimate by 18.18% is likely to negatively impact investor sentiment in the short term, especially considering the stock's positive reaction to the previous quarter's earnings beat. However, the increase in revenue year-over-year may provide some buffer against a steep decline.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100